glp-1 oral medication Ro Launches Wegovy® Pill Through Integration with Novo Nordisk Oral GLP-1: A Needle-Free Solution
Description
On October 5, 2023, an important study, published in JAMA and authored by Mohit Sodhi, indicated an increased risk of gastroparesis, bowel obstruction, and pancreatitis for those using GLP-1 agonists

2018;315:R856-65
Those who shouldnt take GLP-1 agonists include people who: are pregnant, nursing, or planning to become pregnant have a history of thyroid cancer or pancreatitis are allergic or sensitive to any of the GLP-1 medications have multiple endocrine neoplasia (MEN) syndrome type 2 Weight loss medications are not recommended for people with past or active eating disorders

Victoza (liraglutide) : a once-daily injectable GLP-1 receptor agonist, also sold in a higher dose for weight loss under the brand name Saxenda

Your provider can guide you on how to schedule your medications

These comparisons help to clarify MariTides distinctive role among weight loss treatments and emphasize the need for continued research to enhance therapeutic effectiveness
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)